Коагуляционный гемостаз: нарушения, литература
Antonarakis SE: The molecular genetics of hemophilia A and В in man. Factor III and factor IX deficiency. Adv Hum Genet 17:17, 1988
Destefano V et al: Inherited thrombophilia: Pathogenesis, clinical syndromes and management. Blood 87:3531, 1996
Feinstein DI: Lupus anticoagulant, anticardiolipin antibodies, fetal loss and systemic lupus eiythematosus. Blood 80:859, 1992
Giddings JC, Peake IR: Laboratory support in the diagnosis of coagulation disorders. ClinHaematol 14:571, 1985
Ginsburg KJ et al: Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 117:997, 1992
Kane WH, Davie EW: Blood coagulation factors Vand VIII: Structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 71:539, 1988
Kasper CK, Dietrich SL: Comprehensive management of haemophilia. Clin Haematol 14:489, 1985
Lakich D et al: Inversions disrupting the factor VIII gene are a common cause of servere hemophilia A. Nat Genet 5:226, 1993
Lawn R: The molecular genetics of hemophilia. Sci Am 254:48, 1986
Lusher JM et al: Recombinant factor VIII for the treatment of untreated patients with hemophilia A: Safety, efficacy and development of inhibitors. N Engl J Med 328:453, 1993
Mammen E: Congenital coagulation disorders. Semin Thromb Hemost 9:l, 1983
Pierce GF et al: The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost and supply on therapy. JAMA 261:3434, 1989
White GC, Shoemaker CB: Factor VIII gene and hemophilia A. Blood 73:1, 1989
